Tao Jiang
Beijing Neurosurgical Institute · Tangdu hospital, The air force military university · Beijing Tiantan Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Tao Jiang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:24 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT07873996 · Tris-CAR-T Cell Therapy Targeting CD44 and CD133 in Newly Diagnosed GlioblastomaBeijing Tiantan Hospital · not yet recruiting · Newly Diagnosed Glioblastoma, IDH-wildtype · study chair
- Ph2NCT06663059 · Adebrelimab Neoadjuvant Treatment for Resectable ESCC: 2 vs 4 Cycles StudyTang-Du Hospital · recruiting · Esophageal Cancer · study chair
- N/ANCT06161610 · Recurrent High Grade Glioma Treated by LITTBeijing Tiantan Hospital · recruiting · Recurrent High Grade Glioma · principal investigator
- N/ANCT05901844 · Evaluate the Accuracy of Raman IVD Analyzer in the Diagnosis of Gliomas During SurgeryBeijing Tiantan Hospital · unknown · Glioma · principal investigator
- N/ANCT05672043 · Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in ChinaBeijing Tiantan Hospital · recruiting · Medulloblastoma, Central Nervous System Tumor, Pediatric, Ependymoma · principal investigator
- Ph1NCT05577091 · Tris-CAR-T Cell Therapy for Recurrent GlioblastomaBeijing Tiantan Hospital · recruiting · Recurrent Glioblastoma · study chair
- Ph4NCT05387109 · Penpulimab Combined With Anlotinib in Neoadjuvant Treatment of Resectable Non-small Cell Lung CancerTang-Du Hospital · unknown · NSCLC · study chair
- N/ANCT05167604 · Clinical Value of MRD Monitoring for Adjuvant Therapy in Postoperative NSCLCTang-Du Hospital · unknown · Carcinoma, Non-Small-Cell Lung, Next-Generation Sequencing, Chemotherapy, Adjuvant · principal investigator
- N/ANCT05143788 · Strategic Intervention on Preserving Motor Function During Awake CraniotomyBeijing Neurosurgical Institute · unknown · Glioma · study director
- N/ANCT05124964 · Prospective Study on Quality of Life in Patients With Intracranial Germ Cell TumorsBeijing Tiantan Hospital · unknown · Quality of Life · principal investigator
- Ph2NCT05124951 · The Efficacy of WVI in Patients With Localized Basal Ganglia Intracranial Germ Cell TumorsBeijing Tiantan Hospital · unknown · Intracranial Germ Cell CNS Tumor, Childhood · principal investigator
- Ph2NCT05055583 · Toripalimab in Combination With Platinum-based Chemotherapy for Mutation-negative Stage IV Oligometastatic NSCLCTang-Du Hospital · unknown · NSCLC Stage IV, Oligometastasis · principal investigator
- N/ANCT04213313 · Association Between SNP of SP-D and Susceptibility and Prognosis of Infectious KeratitisSecond Affiliated Hospital, Zhejiang University, School of Medicine · completed · Infectious Keratitis · study director
- N/ANCT04116892 · Comparative Analysis of Large Macular Hole SurgeriesSecond Affiliated Hospital, Zhejiang University, School of Medicine · unknown · Macular Holes · principal investigator
- Ph1NCT03734354 · The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese SubjectsOtsuka Beijing Research Institute · completed · Health · principal investigator
- Ph1NCT03734302 · The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy SubjectsOtsuka Beijing Research Institute · completed · Healthy · principal investigator
- Ph1NCT03287505 · Aripiprazole IM Depot for Chinese Patients With SchizophreniaOtsuka Beijing Research Institute · completed · Schizophrenia · principal investigator
- Ph1NCT03285503 · PK Study of Aripiprazole IM Depot for Chinese Patients With SchizophreniaOtsuka Beijing Research Institute · completed · Schizophrenia · principal investigator
- Early Ph1NCT02766270 · CCRT With Temozolomide Versus RT Alone in Patients With IDH Wild-type/TERT Promoter Mutation Grade II/III GliomasBeijing Tiantan Hospital · unknown · Grade II/III Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 2 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:24 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Management and survival rates in patients with glioma in China (2004-2010): a retrospective study from a single-institution.J Neurooncol · 2013137 citationsRCR 4.1
- Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.Neurol Res · 200826 citationsRCR 0.6